Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Rapid Micro Biosystems Q2 EPS $(0.27) Misses $(0.26) Estimate, Sales $7.26M Beat $7.10M Estimate

Author: Benzinga Newsdesk | August 12, 2025 05:32am
Rapid Micro Biosystems (NASDAQ:RPID) reported quarterly losses of $(0.27) per share which missed the analyst consensus estimate of $(0.26) by 3.85 percent. This is a 6.9 percent increase over losses of $(0.29) per share from the same period last year. The company reported quarterly sales of $7.26 million which beat the analyst consensus estimate of $7.10 million by 2.28 percent. This is a 9.73 percent increase over sales of $6.62 million the same period last year.

Posted In: RPID

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist